Park Square is pleased to announce the placement of John Sperzel as Independent Director at Ontera. Ontera is a venture-backed biotechnology company commercializing a platform that uses silicon nanopore chips and proprietary biochemistry to accurately detect and differentiate single molecules, which the company is using to transform point of care testing.
Sperzel currently serves as Chief Executive Officer and President at T2 Biosystems, a publicly traded in vitro diagnostics company. Previously, he served as Chief Executive Officer, President, and Member of the Board of Directors at Chembio Diagnostics, Inc. Prior to this role, Sperzel served as Chief Executive Officer, President, and Member of the Board of Directors at International Technidyne Corporation.
Sperzel received his B.Sc. in Business Administration/Management from Plymouth State College.
Park Square Executive Search serves companies and institutions that are shaping the world through discovery, innovation and growth. Our clients are leading life sciences and healthcare organizations, technology companies, major research universities, and venture capital and private equity firms, including their portfolio companies. We place board members, chief executive officers, C-suite executives, and academic leaders.